Solid Biosciences (SLDB) Misses Q4 EPS by 100c

Solid Biosciences (NASDAQ: SLDB) reported Q4 EPS of ($1.00).

For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.

You May Also Be Interested In

• Antero Resources (AR) PT Raised to $47 at Benchmark on Natural Gas Bull Case
• Sutro Biopharma Inc. (STRO) Misses Q2 EPS by 13c
• Alight names three executives in leaves and broker partnerships